番茄社区app

Cardiology >

CHF

News, opinions and meeting coverage in cardiology.

Wise Buy? Left Ventricular Assist Devices

Getting better and cheaper, but 'nobody wears pink ribbons for heart failure'

Subclavian TAVR Safe When Femoral Access Is Risky

Trial analysis shows similar morbidity, mortality

SAVR Beats Expectations in Intermediate Risk Trial

Lower mortality than surgical risk score predicted in PARTNER 2A

Novartis Pulls Out of Controversial Entresto Contest

Cardiologists named to review panel had quit

CMS to Offer Billing Code for Heart Failure Specialists

Should eliminate denials for appearance of double-billing

Trial: No Benefit for High-Dose Diuretic in Acute HF

But phase II results might not be the final word

AHA: No Pump Thrombosis With Next-Gen LVAD?

Better outcomes in HeartMate 3 trial hinged on fewer malfunctions

AHA: Real World TAVR Is All About Patient Selection

Intermediate risk is a moving target

AHA: Long-Term Benefit in HF Patients Elusive for Novel Vasodilator

Investigational drug ularitide had no effect on mortality or clinical outcomes

TCT: TAVR Holds Up Pretty Well Over Time

Also, 2-year data confirm lasting improvements in QoL

TCT: Embolic Protection Flops for TAVR

New brain lesions or clinical strokes unaffected in SENTINEL trial

CardioBrief: Impella No Better Than IABP in Cardiogenic Shock

Underpowered IMPRESS trial shows no mortality benefit

HFSA: Clinical Benefits Tied To Lung Monitoring Persist

HF rehospitalization, deaths remain reduced up to 4.5 years

Cardiac Myosin Activator Shows Promise for LV Function

'More hands pulling on the rope'

HFSA: Did LAP Monitoring Cut HF Rehospitalizations?

LAPTOP-HF investigators tried to make sense of terminated study

ESC: Beta-Blocker Cuts Early Heart Damage from Cancer Tx?

No clinical difference in small trial, but preclinical measures suggestive

ESC: No Mortality Benefit With ICD in Nonischemic HF

Eleven fewer deaths over 5 years

Stores' Security Systems Can Mess With Cardiac Devices

ICD, pacemaker hiccups seen near anti-shoplifting monitors in lab study

Survival Rates Good With VAD for Complicated Acute MI

Despite being sicker to start, outcomes on par with other VAD patients

Podcast: 10th Anniversary for HealthNewsReview.org

Gary Schwitzer reflects on high points, low points, lessons learned

ACC: After a Decade, CABG Pulls Ahead of Meds for HF

Life-saving benefit of CABG now clear in long-term trial follow-up

Entresto: Why Is There Silence? We're Not Selling iPhones

The drug hailed as a true PARADIGM shift, is slow out of the gate

ACC: TAVR Once Again Non-Inferior to Surgery

No excess stroke or mortality at 2 years in lowest risk trial population yet studied

CardioBrief: Top HF Expert Decries 'Unbelievable Folly' of Clinical Trials and Guidelines

Milton Packer, MD, calls the system to test and evaluate heart failure drugs dysfunctional

CardioBrief: LVADs Prolong Life But Sow Confusion at Its End

Uncertainty dogs heart pump patients and their caregivers

First MRI-Safe CRT-D Devices Approved

Cardiac resynchronization patients may now undergo scans

CardioBrief: Entresto Maker in Deep Water Over Terrifying TV Ad

"Alarmist," "horrifying" and "irresponsible," experts say

CardioBrief: Entresto Off to Slow Start

'Blockbuster' heart failure drug falls short of already low sales expectations

AHA: Long-Acting Nitrate Flops in HFpEF

Study does not support the use of nitrates in subgroup of heart failure patients

Is SAMHSA to Blame for a Broken Mental Health System?

Two members of Congress differ on how to fix a failing system

Safety Warning: Watch LVAD Battery Expiration

Ventricular support backup battery issue linked to two deaths

Clear Health Costs: Having Insurance Doesn't Always Pay

The case of the $1,700 mammogram

CardioBrief: Dollars for Heart Docs

Analysis of CMS database shows some docs pocketed millions from drug and device makers.

10 Questions: Mary Norine Walsh, MD

"The waste will continue until the method of reimbursement changes."

Hyperkalemia Pipeline Promising

Novel agents look good in trials, although long-term safety and efficacy remain to be seen.

Doctor's Memoir Exposes Dark Side of Medicine

Sandeep Jauhar puts his life on stark display to illustrate harmful financial intrusions into medicine in his newest book.

CardioBuzz: Toward the $500 an Hour Physician

In this guest blog, Mark Jay Zucker, MD, JD, an attorney and transplant cardiologist at Rutgers University New Jersey Medical School in Newark, explains why he thinks it's time to talk money.

How To Get Medicare To Cover A Spa Trip

Good news for doctors who think their patients need a trip to the spa: Medicare will reimburse, with only two catches.

How to Replace IV Nitroglycerin in the Shortage

What are the alternatives for IV nitroglycerin in the emergency setting as the shortage saps reserves? Several experts share their thoughts.

CT Appears Safe in Patients With Pacemakers, ICDs

Patients with cardiac rhythm management devices showed no clinically significant major or minor events related to computed tomography imaging over a 10-year period at two large-volume care centers, researchers reported.

鈥�

17